Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:32 PM
Ignite Modification Date:
2025-12-24 @ 12:32 PM
NCT ID:
NCT02904161
Eligibility Criteria:
Inclusion Criteria:
For inclusion in the first stage of the study, subjects must fulfill all of the following criteria:
1. Provision of signed written informed consent before enrollment into the study, ability to communicate with the investigators, and to understand and comply with the requirements of the study.
2. Patients diagnosed with stage 4 breast cancer or other types of cancer or chosen to be part of one of the negative control population cohorts.
For inclusion in the second stage of the study, subjects must fulfill all of the following criteria:
1. Provision of signed written informed consent before enrollment into the study, ability to communicate with the investigators, and to understand and comply with the requirements of the study.
2. Patients diagnosed with breast cancer or other types of cancer or chosen to be part of one of the negative control population cohorts.
Exclusion Criteria:
The following is regarded as a criterion for exclusion from the study and applicable to both 2 stages :
1\. Subject has received any investigational agent within 28 days or 5 half-lives, whichever is longer, prior to the study.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT02904161
Study Brief:
Protocol Section:
NCT02904161